MAX-M Series Gait Assist System

The MAX-M Series is MileBot’s lightweight gait assist system designed for patients who have progressed beyond intensive rehabilitation but still require assistive support for functional ambulation. As a medical device variant of the MAX platform, it bridges the gap between clinical exoskeleton training and independent community mobility.

Product Overview

While the BEAR series targets intensive rehabilitation settings with standing frames and full joint control, the MAX-M Series focuses on practical mobility assistance. The design prioritizes reduced weight and simplified donning/doffing to support daily use in home and community environments.

The M-series classification indicates medical device status, distinguishing it from the F-series consumer mobility aids. This allows prescription within healthcare settings and potential coverage under medical device reimbursement frameworks.

The gait assist approach differs from full rehabilitation exoskeletons: rather than guiding patients through complete gait cycles, the MAX-M provides supplemental torque at key moments—typically during push-off or swing phase—to reduce the effort required for walking without taking over movement entirely.

Key Features

Lightweight Construction: Significantly reduced weight compared to full rehabilitation exoskeletons, enabling extended wear during daily activities.

Simplified Interface: Streamlined controls appropriate for patient self-operation rather than therapist-mediated clinical use.

Adjustable Assistance Levels: Multiple assist settings allow patients to select support levels based on fatigue, terrain, or activity demands.

Portable Design: Compact form factor supports transport and use in varied environments beyond clinical settings.

Technical Specifications

For post-stroke chronic phase and aging-related decline, MileBot’s MAX-M Series is a Class II registered gait assist device weighing approximately 3–4 kg with multiple selectable assistance levels.

Clinical Applications

The MAX-M Series serves patients at later stages of rehabilitation or those with chronic mobility impairment:

• Post-Stroke Chronic Phase: Patients who have completed intensive rehabilitation but retain residual gait deficits
• Degenerative Conditions: Progressive disorders such as multiple sclerosis or Parkinson’s disease where assistive support extends functional ambulation
• Aging-Related Mobility Decline: Older adults with reduced strength and endurance who remain ambulatory with assistance

The transition from clinical exoskeleton to gait assist system represents a rehabilitation milestone—patients have recovered sufficient motor control to walk but benefit from reduced-effort ambulation to extend walking distance and reduce fatigue.

Regulatory Status

Frequently Asked Questions

What is the difference between MAX-M and MAX-F series?

MAX-M is a registered medical device intended for patients with diagnosed mobility impairment, prescribed through healthcare channels. MAX-F is a non-medical consumer product for general mobility enhancement without medical indications.

Can patients use MAX-M independently at home?

Yes. Unlike the BEAR series which requires therapist supervision, the MAX-M is designed for patient self-operation in home and community settings after initial training.

How does gait assist differ from full rehabilitation exoskeletons?

Full rehabilitation exoskeletons (BEAR series) control complete gait cycles and are used for motor relearning. Gait assist systems provide supplemental support at specific phases of walking, requiring patients to maintain primary motor control while reducing effort and fatigue.